By Nigam Arora 215 Buyouts — A New Record of Success for Arora Members Avidity Biosciences (RNA) has received a buyout offer from Novartis (NVS) for approximately $12B. RNA is the 215th Arora Portfolio company to be bought out. This milestone demonstrates the strength of The Arora Report’s approach. Neuromuscular Diseases
By Nigam Arora This post was published yesterday in The Arora Report paid feeds as an Afternoon Capsule. To gain an edge, this is what you need to know now. Two Fed Governors Dissent Please click here for a chart of S&P 500 ETF (SPY) which represents the benchmark stock market
This post was just published on ZYX Buy Change Alert. The Supreme Court is likely to make a ruling on Obamacare this month. It is always difficult to predict judicial decisions, it appears that the ruling is likely to go in the favor of Obamacare but you never know. For this
In the United States, 50,000 people die from colon cancer each year and 140,000 new cases are reported every year. As cancer goes, colon cancer is second only to lung cancer as the biggest killer in the United States. Fortunately, for the most part, colon cancer is easily preventable because